U.S., Feb. 5 -- ClinicalTrials.gov registry received information related to the study (NCT06807762) titled 'Safety and Pharmacokinetics of Extrato De Cannabis Sativa GreenCare' on Jan. 17.
Brief Summary: The goal of this Phase I clinical trial is to assess the pharmacokinetic availability and safety and tolerability profile of Extrato de Cannabis sativa GreenCare 79.14 mg/mL. The main question it aims to answer is:
* Is the Extrato de Cannabis sativa GreenCare 79,14 mg/mL safe?
Study Start Date: March 10
Study Type: INTERVENTIONAL
Condition:
Healthy
Intervention:
DRUG: Cannabis oil
Healthy subjects will be treated with a solution of Cannabis sativa extract diluted in MCT oil, at doses ranging from 39.62 mg to 791.4 mg. This protoco...